All Articles

A new documentary on Soca king Machel Montano is more than a biopic. It’s a case study in building a global industry from a cultural resource.

A new documentary is bypassing traditional media gatekeepers with an innovative distribution model. Here’s how 'Seeds for Liberation' is building a movement.

As it turns 100, advisory firm Richter is expanding to Calgary. It's a strategic move into a competitive market, betting on a new model for family wealth.

A U.S. export license for Microchip in Armenia is more than a corporate win; it's a strategic play reshaping global tech supply chains and U.S. influence.

A new partnership between FusionAIrre and Schneider Downs uses agentic AI to overhaul corporate assurance, turning a costly bottleneck into a strategic engine.

A record $98.3T in HNWI wealth creates a fierce battle for assets, as traditional firms lose ground to tech-savvy rivals and AI-driven personalization.

A top Virginia cancer practice has been chosen to train US doctors in a breakthrough radiopharmaceutical therapy, a strategic move to break a key training bottleneck.

A Florida biotech is using a novel gene therapy to correct aging-related errors. But the real story is its funding: a decentralized, crypto-style model.

A new government survey aims to tackle the costly maze of interprovincial rules for services. For businesses, this is a critical chance to shape a truly national market.

A new cloud platform is giving U.S. forces unprecedented real-time control over satellite comms, slashing admin time and boosting battlefield effectiveness.

A new podcast, The Golden Ball, teams a World Cup star with Jungian experts to explore how soccer's drama offers a powerful playbook for personal growth.

The opening of a new eating disorder clinic is more than an expansion. It's a calculated response to a growing crisis and a model for strategic healthcare growth.

A new partnership aims to solve AI's reliability problem by giving it a memory, turning scattered corporate data into a strategic, trustworthy asset.

Syndax Pharmaceuticals secures a $250M war chest via convertible notes. We decode the deal, what it means for its cancer drugs, and why it's a savvy move.

After years of losses, Wisconsin-based Orion Energy Systems reports a stunning financial recovery. But can its new CEO sustain this momentum in the volatile green-tech market?

As Ontario launches a $200B+ infrastructure blitz, CanLift Equipment bets big with a major fleet expansion, aiming to become the single-source solution for contractors.

With an FDA decision just weeks away, Ionis's olezarsen could redefine care for a debilitating condition, marking a pivotal moment for RNA-targeted medicine.

Beyond a simple clothing line, the new Jeep and vineyard vines collaboration is a masterclass in leveraging heritage and patriotism for modern market dominance.

As Insulet unveils pivotal data, a deeper look reveals a strategy to not just improve tech, but to fundamentally change the daily reality of diabetes.

Hivemind Capital and UC Berkeley launch darkmatter lab, a novel model to inject capital and resources into frontier research before it becomes a company.